Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

Journal of the American College of Surgeons

Volumn 206, Issue 5, 2008, Pages 833-846

  Katz, Matthew H G ^a   Pisters, Peter W T ^a   Evans, Douglas B ^a   Sun, Charlotte C ^a   Lee, Jeffrey E ^a   Fleming, Jason B ^a   Vauthey, J Nicolas ^a   Abdalla, Eddie K ^a   Crane, Christopher H ^a   Wolff, Robert A ^a   Varadhachary, Gauri R ^a   Hwang, Rosa F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; GEMCITABINE; PACLITAXEL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SUPERIOR MESENTERIC VEIN; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS; TREATMENT RESPONSE; VEIN OCCLUSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; RADIOTHERAPY;

EID: 43049106807     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.12.020     Document Type: Article

References (13)

1. Raut C.P., Tseng J.F., Sun C.C., et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246 (2007) 52-60
2. Wolff R.A., Crane C., Li D., et al. Neoplasms of the exocrine pancreas. In: Kufe D.W., et al. (Ed). Cancer medicine. 8th ed. (2006), BC Decker, London 1331-1358
3. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology. Pancreatic adenocarcinoma. http://www.nccn.org/professionals/physician_gls/default.asp Accessed February 6, 2008
4. Varadhachary G.R., Tamm E.P., Abbruzzese J.L., et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13 (2006) 1035-1046
5. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
6. Evans D.B., Lee J.E., Tamm E.P., and Pisters P.W. Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer. In: Fischer J.F. (Ed). Mastery of surgery (2007), Lippincott Williams & Wilkins, Philadelphia 1299-1317
7. Gallagher S.F., Zervos E.E., and Murr M.M. Distal pancreatectomy. In: Von Hoff D.D., Evans D.B., Hruban R.H., et al. (Eds). Pancreatic cancer (2005), Jones and Bartlett, Sudbury, MA 299-312
8. Yen T.W.F., Abdalla E.K., Pisters P.W., and Evans D.B. Pancreaticoduodenectomy. In: Von Hoff D.D., Evans D.B., Hruban R.H., et al. (Eds). Pancreatic cancer (2005), Jones and Bartlett, Sudbury, MA 299-312
9. Tseng J.F., Raut C.P., Lee J.E., et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8 (2004) 935-949 discussion 949-950
10. Pisters P.W., Hudec W.A., Hess K.R., et al. Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 234 (2001) 47-55
11. Staley C.A., Cleary K.R., Abbruzzese J.L., et al. The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 12 (1996) 373-380
12. th ed. (2002), Springer-Verlag, Chicago 157-164
13. Evans D.B., Rich T.A., Byrd D.R., et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 127 (1992) 1335-1339